PharmaTher Expands Patent Portfolio for Ketamine and Repurposing of Psychedelics with panaceAI™ Apr 27, 2021
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the… Apr 20, 2021